The status of postoperative therapy using iodine-131 in differentiated thyroid carcinoma

ZHANG Jie; SHI Hong-cheng

doi:10.3760/cma.j.issn.1673-4114.2009.03.009

ZHANG Jie, SHI Hong-cheng. The status of postoperative therapy using iodine-131 in differentiated thyroid carcinoma[J]. Int J Radiat Med Nucl Med, 2009, 33(3): 163-167. DOI: 10.3760/cma.j.issn.1673-4114.2009.03.009

Citation:

ZHANG Jie, SHI Hong-cheng. The status of postoperative therapy using iodine-131 in differentiated thyroid carcinoma[J]. Int J Radiat Med Nucl Med, 2009, 33(3): 163-167. DOI: 10.3760/cma.j.issn.1673-4114.2009.03.009

Citation:

ZHANG Jie, SHI Hong-cheng. The status of postoperative therapy using iodine-131 in differentiated thyroid carcinoma[J]. Int J Radiat Med Nucl Med, 2009, 33(3): 163-167. DOI: 10.3760/cma.j.issn.1673-4114.2009.03.009

The status of postoperative therapy using iodine-131 in differentiated thyroid carcinoma

Abstract

Abstract

The systemic treatment of differentiated thyroid carcinoma include thyroidectomy, radioactive iodine and thyroxine suppression of thyroid-stimulating hormone. The effectivity of the iodine-131 therepy were well accepted, but still some of issues were still debatable.

FullText(HTML)